<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03249454</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-17-0166</org_study_id>
    <nct_id>NCT03249454</nct_id>
  </id_info>
  <brief_title>Effects of Transcutaneous Spinal Direct Current Stimulation in Incomplete Spinal Cord Injury</brief_title>
  <official_title>Effects of Transcutaneous Spinal Direct Current Stimulation in Incomplete Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TIRR/Mission Connect</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effects of a novel therapeutic approach with
      transcutaneous spinal direct current stimulation (tsDCS) to promote functional recovery and
      spasticity in chronic spinal cord injury (SCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to investigate the effects of a novel therapeutic approach to
      promote functional recovery and spasticity in chronic SCI. The tsDCS effect on
      neuro-physiological measures such as H reflex and somatosensory evoked potential (SSEP) wiil
      be evaluated in subjects with SCI. This incremental, design will allow the establishment of
      strong electrophysiological data prior to rapid clinical translation of the findings about
      this promising, early-stage technique.

      The central hypothesis is twofold: 1) active tsDCS will lead to a change in Hmax/M max ratio
      than sham tsDCS, in a polarity dependent manner; and 2) active tsDCS will lead to a change in
      SSEP amplitude and latency, in a polarity dependent manner.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover design with 3 arms: Anodal tsDCS, Cathodal tsDCS, Sham tsDCS</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Hmax/M max ratio</measure>
    <time_frame>10 minutes before intervention, 10 minutes after intervention ( for each intervention)</time_frame>
    <description>Immediately before application of tsDCS and after application of tsDCS Hmax and Mmax will be obtained from soleus muscle by stimulation of tibial nerve. The H-reflex is a compound muscle action potential elicited by low-threshold electrical stimulation of afferent fibers in the mixed nerve with subsequent monosynaptic excitation of alpha motoneurons. Changes in the excitability of the reflex pathway are estimated by measuring the amplitude of the reflex. M wave is a compound muscle action potential produced by direct supra-maximal stimulation of motor axons.changes in the ratio of maximal H-reflex amplitude and maximal M-wave amplitude (Hmax/Mmax) provide a rough estimate of modulation in spinal excitability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in SSEPs</measure>
    <time_frame>30 to 40 minutes before intervention, 30 to 40 minutes after intervention ( for each intervention)</time_frame>
    <description>SSEPs measurements to evaluate effects of tsDCS on ascending somatosensory pathways.A somatosensory evoked potential (SSEP) is the electrical activity response measured at the skin's surface along ascending sensory pathway following controlled peripheral nerve stimulation. For recording posterior tibial nerve SSEPs, the nerve is stimulated at the ankle, with the cathode midway between the Achilles tendon and the medial malleolus and the anode 3 cm distal to the cathode. Nerve stimulation should consist of a 0.1-0.2 ms duration square wave pulse at 3-5 Hertz (Hz). These pulses will be delivered by constant voltage stimulator applied transcutaneously over the targeted nerve. The stimulation intensity would exceed the motor threshold for eliciting a muscle twitch. Electromyogram (EMG)/ Nerve Conduction Velocity (NCV) measuring system will be used to measure SSEPs. Procedure will follow per clinical protocol.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score on Modified Ashworth Scale</measure>
    <time_frame>within 60 days of first intervention</time_frame>
    <description>The Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change Systolic Blood Pressure</measure>
    <time_frame>60 to 90 minutes before intervention,60 to 90 minutes after intervention ( for each intervention)</time_frame>
    <description>Systolic Blood pressure will be recorded before and after delivering each intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate</measure>
    <time_frame>60 to 90 minutes before intervention,60 to 90 minutes after intervention ( for each intervention)</time_frame>
    <description>Heart rate will be recorded before and after delivering each intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Diastolic Blood Pressure</measure>
    <time_frame>60 to 90 minutes before intervention,60 to 90 minutes after intervention ( for each intervention)</time_frame>
    <description>Diastolic Blood pressure will be recorded before and after delivering each intervention</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Incomplete Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Cathodal tsDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will be assigned to receive two cathodal tsDCS interventions randomly. There will be at least 1 week washout period between any 2 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anodal tsDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will be assigned to receive two anodal tsDCS interventions randomly. There will be at least 1 week washout period between any 2 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tsDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Each subject will be assigned to receive one sham tsDCS interventions randomly. There will be at least 1 week washout period between any 2 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anodal tsDCS</intervention_name>
    <description>During Anodal tsDCS intervention the positive end of the battery will be connected to the electrode on participant's back and negative end of the battery will be connected to the electrode on participant's shoulder. The battery will be turned on for 15 minutes, and the stimulation strength will be adjusted a couple of times per tolerance level.</description>
    <arm_group_label>Anodal tsDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cathodal tsDCS</intervention_name>
    <description>During Cathodal tsDCS intervention the negative end of the battery will be connected to the electrode on participant's back and positive end of the battery will be connected to the electrode on participant's shoulder. The battery will be turned on for 15 minutes, and the stimulation strength will be adjusted a couple of times per tolerance level.</description>
    <arm_group_label>Cathodal tsDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tsDCS</intervention_name>
    <description>During Sham tsDCS intervention, battery will be turned off and no current will pass through the electrodes.</description>
    <arm_group_label>Sham tsDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Providing written informed consent prior to any study related procedures

          -  18-50 years of age

          -  Motor incomplete SCI classified as C or D by the American Spinal Injury Association
             Impairment Scale (AIS)

          -  Traumatic lesion at or above T8-T9 neurological level

          -  Body mass index â‰¤ 30 (in order to facilitate reliable location of body landmarks
             guiding stimulation);

          -  Chronic SCI (time since injury&gt;6 months)

        Exclusion Criteria:

          -  Unstable cardiopulmonary conditions

          -  History of seizure, head injury with loss of consciousness, severe alcohol or drug
             abuse, and/or psychiatric illness

          -  Any joint contracture or severe spasticity, as measured by a Modified Ashworth Score 4

          -  Subject who cannot provide self-transportation to the study location

          -  Cardiac or neural pacemakers

          -  Pregnancy

          -  lower motor neuron injury (eg: peripheral neuropathy, cauda equina syndrome)

          -  Uncontrolled diabetes with HbA1C&gt;7

          -  History of severe autonomic dysreflexia

          -  No planned alteration in therapy or medication for muscle tone during the course of
             the study(No botulinum toxin injections in last 3 months, No phenol injections in last
             6 months, intrathecal baclofen pump dose stable for past 3 months, etc)

          -  Conditions for e.g., severe arthritis, extreme shoulder pain that would interfere with
             valid administration of the measures or with interpreting motor testing;

          -  No contraindications to tsDCS

          -  ferromagnetic material in the brain or in the spine (except for titanium used in
             segmental)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Radha Korupolu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Radha Korupolu, MD</last_name>
    <phone>713-797-5233</phone>
    <email>Radha.Korupolu@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruta Paranjape, MS, CCRP</last_name>
    <phone>713-799-6976</phone>
    <email>ruta.paranjape@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radha Korupolu, MD</last_name>
      <phone>713-797-5233</phone>
      <email>Radha.Korupolu@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ruta Paranjape, MS, CCRP</last_name>
      <phone>713-799-6976</phone>
      <email>ruta.paranjape@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2017</study_first_submitted>
  <study_first_submitted_qc>August 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Radha Korupolu</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Incomplete SCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

